Patent · US Active

Phthalazinone compound, and preparation method therefor and medical use thereof

US12234223B2 · kind B2 · utility

0Cited by

1References

30Claims

0Family size

Assignees

SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. · CN
JIANGXI JEMINCARE GROUP CO., LTD · CN

Inventors

Hongfu Lu · Shanghai, CN
Weiqiang XING · Shanghai, CN
Yongcong Lv · Shanghai, CN
Baojian Qi · Shanghai, CN
Jianbiao PENG · Shanghai, CN
Haibing GUO · Shanghai, CN

Key dates

Filing date	Aug 14, 2024
Grant date	Feb 25, 2025
Priority date	—
Expiry date	Aug 14, 2044

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a phthalazinone compound, and a preparation method therefor and the medical use thereof. In particular, disclosed are a compound as represented by formula (I), and a pharmacodynamically acceptable salt, and the use of the compound as an androgen receptor (AR) for degradation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.